Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates

Health Affairs

Volumn 35, Issue 7, 2016, Pages 1324-1332

  Patrick, Stephen W ^a   Fry, Carrie E ^a   Jones, Timothy F ^b   Buntin, Melinda B ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TENNESSEE DEPARTMENT OF HEALTH   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ALABAMA; ARTICLE; DRUG ABUSE; DRUG INTOXICATION; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; ILLINOIS; INDIANA; KENTUCKY; LOUISIANA; MARYLAND; MISSISSIPPI; MORTALITY RATE; NEBRASKA; NEVADA; NEW MEXICO; OKLAHOMA; OPIOID RELATED OVERDOSE; PRESCRIPTION; PRESCRIPTION DRUG MONITORING PROGRAM; SOCIOECONOMICS; TEXAS; UNEMPLOYMENT; UTAH; WEST VIRGINIA; ADULT; AGED; CHRONIC PAIN; CLINICAL TRIAL; COHORT ANALYSIS; DRUG MONITORING; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TRENDS; UNITED STATES;

ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; COHORT STUDIES; DATABASES, FACTUAL; DRUG MONITORING; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; RISK ASSESSMENT; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84980368213     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2015.1496     Document Type: Article

References (48)

1. Centers for Disease Control and Prevention. Vital Signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb MortalWkly Rep. 2011;60(43): 1487-92.
2. Paulozzi LJ, Mack KA, Hockenberry JM. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines-United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):563-8.
3. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012; 307(18):1934-40.
4. Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):667.
5. Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):842-50.
6. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013; 62(26):537-42.
7. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50): 1378-82.
8. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613-20.
9. Mack KA, Zhang K, Paulozzi L, Jones C. Prescription practices involving opioid analgesics among Americans with Medicaid, 2010. J Health Care Poor Underserved. 2015;26(1):182-98.
10. Miller M, Barber CW, Leatherman S, Fonda J, Hermos JA, Cho K, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med. 2015;175(4):608-15.
11. Government Accountability Office. Prescription drugs: state monitoring programs provide useful tool to reduce diversion [Internet]. Washington (DC): GAO; 2002 May [cited 2016 May 12]. (Publication No. GAO-02-634). Available from: http://www.gao.gov/new.items/d02634.pdf
12. Executive Office of the President of the United States. Epidemic: responding to America's prescription drug abuse crisis [Internet]. Washington (DC): White House; 2011 [cited 2016 May 12]. Available from: https://www.whitehouse.gov/sites/default/files/ondcp/policy-andresearch/rx_abuse_plan.pdf
13. Drug Enforcement Administration, Office of Diversion Control. State prescription drug monitoring programs [Internet]. Springfield (VA): The Office; [cited 2016 May 12]. Available from: http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm
14. Prescription Drug Monitoring Program Training and Technical Assistance Center. Status of prescription drug monitoring programs (PDMPs) [Internet]. Waltham (MA): The Center; 2014 [cited 2016 May 12]. Available from: http://www.pdmpassist.org/pdf/PDMPProgramStatus2014.pdf
15. Schwarz A. Missouri alone in resisting prescription drug database. New York Times. 2014 Jul 20.
16. Prescription Drug Monitoring Program Center of Excellence at Brandeis. Briefing on PDMP effectiveness [Internet]. Waltham (MA): The Center; [updated 2013 Apr cited 2016 May 12]. Available from: http://www.pdmpexcellence.org/sites/all/pdfs/briefing_PDMP_effectiveness_april_2013.pdf
17. Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145: 34-47.
18. Paulozzi LJ, Kilbourne EM, Desai HA. Prescription drug monitoring programs and death rates from drug overdose. Pain Med. 2011;12(5):747-54.
19. Li G, Brady JE, Lang BH, Giglio J, Wunsch H, DiMaggio C. Prescription drug monitoring and drug overdose mortality. Inj Epidemiol. 2014;1(9).
20. LawAtlas. The policy surveillance portal [Internet]. Philadelphia (PA): LawAtlas; [cited 2016 May 12]. Available from: http://lawatlas.org/query?dataset=corey-matt-pmp
21. Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP legislation and operational dates [Internet]. Waltham (MA): The Center; [cited 2016 May 25]. Available from: http://www.pdmpassist.org/content/pdmp-legislation-operational-dates
22. O'Connell S. SJR 20: prescriptiondrug abuse: state prescription drug monitoring program practices [Internet]. Helena (MT): Montana Legislature; 2013 Jan [cited 2016 May 12]. Available from: http://leg.mt.gov/content/Committees/Interim/2013-2014/Children-Family/Committee-Topics/SJR20/sjr20-prescription-drug-monitoringprogram-practices-jan2014.pdf
23. National Alliance for Model State Drug Laws. Compilation of prescription monitoring program maps [Internet]. Charlottesville (VA): NAMSDL; c 2015 [cited 2016 May 12]. Available from: http://www.namsdl.org/library/F2582E26-ECF8-E60AA2369B383E97812B/
24. Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668-73.
25. Rönkä S, Karjalainen K, Vuori E, Mäkelä P. Personally prescribed psychoactive drugs in overdose deaths among drug abusers: a retrospective register study. Drug Alcohol Rev. 2015;34(1):82-9.
26. Lanier WA, Johnson EM, Rolfs RT, Friedrichs MD, Grey TC. Risk factors for prescription opioid-related death, Utah, 2008-2009. Pain Med. 2012;13(12):1580-9.
27. Department of Labor, Bureau of Labor Statistics. Local area unemployment statistics [Internet]. Washington (DC): BLS; [cited 2016 May 12]. Available from: http://www.bls.gov/lau/
28. American FactFinder. Community facts [Internet]. Washington (DC): Census Bureau; [cited 2016 May 12]. Available from: http://factfinder.census.gov/
29. Census Bureau. American Community Survey (ACS) [home page on the Internet]. Washington (DC): Census Bureau; [cited 2016 May 12]. Available from: http://www.census.gov/acs/www/
30. Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506-11.
31. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009; 20(4):488-95.
32. Centers for Disease Control and Prevention. CDC WONDER: about underlying cause of death, 1999-2014 [Internet]. Atlanta (GA): CDC; [cited 2016 May 12]. Available from: http://wonder.cdc.gov/ucd-icd10.html
33. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013; 309(7):657-9.
34. Ray WA, Chung CP, Murray KT, Cooper WO, Hall K, Stein CM. Outof-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med. 2015; 175(3):420-7.
35. Rutkow L, Chang H, Daubresse M, Webster D, Stuart EA, Alexander GC. Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med. 2015;175(10): 1642-9.
36. Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B. Decline in drug overdose deaths after state policy changes-Florida, 2010-2012. MMWR Morb Mortal Wkly Rep. 2014;63(26):569-74.
37. Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies-tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063-6.
38. Bagley SM, Peterson J, Cheng DM, Jose C, Quinn E, O'Connor PG, et al. Overdose education and naloxone rescue kits for family members of individuals who use opioids: characteristics, motivations, and naloxone use. Subst Abus. 2015;36(2): 149-54.
39. Cassidy TA, DasMahapatra P, Black RA, Wieman MS, Butler SF. Changes in prevalence of prescription opioid abuse after introduction of an abusedeterrent opioid formulation. Pain Med. 2014;15(3):440-51.
40. Prescription Drug Monitoring Program Center of Excellence at Brandeis. Mandating PDMP participation by medical providers: current status and experience in selected states [Internet]. Waltham (MA): The Center; 2014 Feb [cited 2016 May 12]. (COE Briefing). Available from: http://www.pdmpexcellence.org/sites/all/pdfs/COE%20briefing%20on%20mandates%20revised_a.pdf
41. Prescription Drug Monitoring Program Training and Technical Assistance Center. Drug schedules monitored [Internet]. Waltham (MA): The Center; [cited 2016 May 25]. Available from: http://www.pdmpassist.org/content/drug-schedulesmonitored
42. Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP data collection frequency [Internet]. Waltham (MA): The Center; [cited 2016 May 25]. Available from: http://www.pdmpassist.org/content/pdmp-data-collection-frequency
43. Centers for Disease Control and Prevention. Prevention for states [Internet]. Atlanta (GA): CDC; [last updated 2016 Mar 15; cited 2016 May 13]. Available from: http://www.cdc.gov/drugoverdose/states/state_prevention.html
44. Prescription Drug Monitoring Program PDMP Training and Technical Assistance Center. Technical assistance guide No. 04-13: funding options for prescription drug monitoring programs [Internet]. Waltham (MA): The Center; 2013 Jul 3 [cited 2016 May 13]. Available from: http://www.pdmpassist.org/pdf/PDMP_Funding_Options_TAG.pdf
45. American Medical Association. Florida prescription drug monitoring program in jeopardy. amednews. com [serial on the Internet]. 2010 Sep 28 [cited 2016 May 13]. Available from: http://www.amednews.com/article/20100928/business/309289997/8/
46. Hinman M. Bondi saves Fasano's prescription drug program with $2M pledge. Laker/Lutz News [serial on the Internet]. 2014 May 5 [cited 2016 May 13]. Available from: http://lakerlutznews.com/lln/?p=18469
47. Rutkow L, Turner L, Lucas E, Hwang C, Alexander GC. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Aff (Millwood). 2015;34(3): 484-92.
48. Deyo RA, Irvine JM, Millet LM, Beran T, O'Kane N, Wright DA, et al. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. Health Aff (Millwood). 2013;32(3):603-13.